Literature DB >> 5584949

Hypercoagulable state induced in humans by the intravenous administration of purified ellagic acid.

A Girolami, E E Cliffton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5584949

Source DB:  PubMed          Journal:  Thromb Diath Haemorrh        ISSN: 0340-5338


× No keyword cloud information.
  7 in total

1.  Failure of ellagic acid to affect platelet aggregation in normal and in factor XII deficient plasma.

Authors:  A Girolami; L Virgolini; R Peruffo; L de Marco
Journal:  Blut       Date:  1975-08

Review 2.  Arterial and venous thrombosis in patients with von Willebrand's disease: a critical review of the literature.

Authors:  A Girolami; F Tezza; M Scapin; S Vettore; A Casonato
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

3.  Decrease of normotest/thrombotest discrepancy in non-contacted coumarin plasma after glass or ellagic acid activation.

Authors:  A Girolami; G Patrassi; A Burul
Journal:  Blut       Date:  1976-07

4.  Lack of inhibition of ellagic acid induced hypercoagulable state and lack of thrombosis in the dog after PAMBA administration.

Authors:  A Girolami; A Brunetti; G Cella; S Pedrazzoli
Journal:  Blut       Date:  1977-05

5.  Activation of factors XII and XI in thrombogenesis.

Authors:  H L Nossel
Journal:  Bull N Y Acad Med       Date:  1972-02

Review 6.  Prethrombotic, prothrombotic, thrombophilic states, hypercoagulable state, thrombophilia etc.: semantics should be respected even in medical papers.

Authors:  A Girolami; E Cosi; S Ferrari; A M Lombardi; B Girolami
Journal:  J Thromb Thrombolysis       Date:  2017-04       Impact factor: 2.300

7.  Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: exceptional activity of ellagic acid.

Authors:  A W Wood; M T Huang; R L Chang; H L Newmark; R E Lehr; H Yagi; J M Sayer; D M Jerina; A H Conney
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.